CMV Colitis Mimicking Crohn’s Disease in a Patient with CLL: A Case Report

Eddy Fares, M. Hoteit, Saliba R. Wehbe, A. Bahr
{"title":"CMV Colitis Mimicking Crohn’s Disease in a Patient with CLL: A Case Report","authors":"Eddy Fares, M. Hoteit, Saliba R. Wehbe, A. Bahr","doi":"10.38179/ijcr.v3i1.38","DOIUrl":null,"url":null,"abstract":"Background: Cytomegalovirus (CMV) infections are common, especially in immunocompromised patients. These infections are usually asymptomatic but can become symptomatic in immunocompromised individuals, with colitis being the second most common presentation of end-organ disease. CMV colitis can mimic Inflammatory Bowel Disease (IBD) or cause an IBD flare, thus making the diagnosis challenging.\nCase Report: We describe the case of a 69-year-old male known to have Chronic Lymphocytic Leukemia (CLL) maintained in remission on venetoclax, a BCL-2 inhibitor. The patient was recently started on mesalamine and steroids after a Crohn’s Disease (CD) diagnosis three weeks before presentation. The patient presented with bloody diarrhea and abdominal pain. His workup included a colonoscopy that showed skip lesions (diffuse ulcerated lesions separated by areas of normal mucosa), a characteristic of CD. Ileal and colonic biopsies were sent for Polymerase Chain Reaction (PCR) of CMV and turned out positive. Therefore, the patient was diagnosed with CD with superimposed CMV colitis. We started the patient on ganciclovir. Three months later, a repeat colonoscopy revealed complete resolution of mucosal ulcerations, practically changing the diagnosis to an isolated CMV colitis mimicking CD.\nConclusion: An isolated CMV colitis can mimic CD, and physicians must consider this entity in their differential diagnosis. This case is additionally remarkable because CLL and the use of a BCL-2 inhibitor usually have a protective role against CMV disease, but this was not the case for our patient.","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical research & trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38179/ijcr.v3i1.38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cytomegalovirus (CMV) infections are common, especially in immunocompromised patients. These infections are usually asymptomatic but can become symptomatic in immunocompromised individuals, with colitis being the second most common presentation of end-organ disease. CMV colitis can mimic Inflammatory Bowel Disease (IBD) or cause an IBD flare, thus making the diagnosis challenging. Case Report: We describe the case of a 69-year-old male known to have Chronic Lymphocytic Leukemia (CLL) maintained in remission on venetoclax, a BCL-2 inhibitor. The patient was recently started on mesalamine and steroids after a Crohn’s Disease (CD) diagnosis three weeks before presentation. The patient presented with bloody diarrhea and abdominal pain. His workup included a colonoscopy that showed skip lesions (diffuse ulcerated lesions separated by areas of normal mucosa), a characteristic of CD. Ileal and colonic biopsies were sent for Polymerase Chain Reaction (PCR) of CMV and turned out positive. Therefore, the patient was diagnosed with CD with superimposed CMV colitis. We started the patient on ganciclovir. Three months later, a repeat colonoscopy revealed complete resolution of mucosal ulcerations, practically changing the diagnosis to an isolated CMV colitis mimicking CD. Conclusion: An isolated CMV colitis can mimic CD, and physicians must consider this entity in their differential diagnosis. This case is additionally remarkable because CLL and the use of a BCL-2 inhibitor usually have a protective role against CMV disease, but this was not the case for our patient.
CLL患者的巨细胞病毒结肠炎模拟克罗恩病:1例报告
背景:巨细胞病毒(CMV)感染是常见的,特别是在免疫功能低下的患者中。这些感染通常无症状,但免疫功能低下的个体可能出现症状,结肠炎是终末器官疾病的第二大常见表现。巨细胞病毒结肠炎可以模拟炎症性肠病(IBD)或引起IBD发作,因此使诊断具有挑战性。病例报告:我们描述了一个69岁的男性慢性淋巴细胞白血病(CLL)的情况下,维持缓解的venetoclax, BCL-2抑制剂。在克罗恩病(CD)诊断三周后,患者最近开始使用美沙拉明和类固醇。病人表现为腹泻带血和腹痛。他的检查包括结肠镜检查,发现跳跃性病变(被正常粘膜区隔开的弥漫性溃疡性病变),这是乳糜泻的特征。回肠和结肠活检检测巨细胞病毒聚合酶链反应(PCR),结果呈阳性。因此,患者被诊断为乳糜泻合并巨细胞病毒结肠炎。我们给病人开了更昔洛韦。三个月后,复查结肠镜检查显示粘膜溃疡完全消退,实际上将诊断改变为孤立性巨细胞病毒结肠炎模拟CD。结论:孤立性巨细胞病毒结肠炎可以模拟CD,医生在鉴别诊断时必须考虑这一因素。另外,由于CLL和BCL-2抑制剂的使用通常对CMV疾病具有保护作用,因此该病例值得注意,但我们的患者并非如此。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信